CompletedNot Applicable

The Role of Natural Orifice Specimen Extraction Surgery (NOSES) in Treating Right-sided Colon Cancer

China349 participantsStarted 2018-01-01

Plain-language summary

The purpose of this study is to investigate the short-term and long-term outcomes between natural orifice specimen extraction surgery (NOSES) and totally laparoscopic right hemicolectomy (TLRH). The hypothesis is that NOSES could achieve good short-term and oncological outcomes for right colon cancer patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Biopsy proven colon carcinoma;
✓. Imaging diagnosis of T1-3 colon cancer;
✓. The tumor located in the cecum, ascending colon, or colonic hepatic flexure;
✓. Written informed consent;

Exclusion criteria

✕. Complete intestinal obstruction;
✕. Hepatitis activity and peripheral neuropathy (such as peripheral neuritis, pseudo meningitis, motor neuritis, and sensory impairment);
✕. Significant organ dysfunction or other significant diseases, including clinically relevant coronary artery disease, cardiovascular disease, or myocardial infarction within the 12 months before enrollment; severe neurological or psychiatric history; severe infection; active disseminated intravascular coagulation;
✕. Pregnancy or breastfeeding;
✕. Alcohol abuse or drug addiction;
✕. Concurrent uncontrolled medical condition;

What they're measuring

The rate of postoperative complications

Timeframe: up to 30 days

Trial details

NCT IDNCT06753968

SponsorNational Cancer Center, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-01

View on ClinicalTrials.gov More Colon Cancer trials